Miguel Ángel Tejada
No ORCID on file
· 2 papers in corpus
· active 2024-2025
BACKGROUND: P2X3 and P2X2/3 receptors are promising therapeutic targets for pain treatment and selective inhibitors are under evaluation in ongoing clinical trials. Here we aim to consolidate and quantitatively evaluate the preclinical evid…